Risk/Benefit Analysis for the Use and Approval of Thrombolytic, Antiarrhythmic, and Hypolipidemic Agents

Proceedings of the Ninth Annual Symposium on New Drugs & Devices, October 27 & 28, 1988

Nonfiction, Health & Well Being, Medical, Specialties, Internal Medicine, Cardiology

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

Big bigCover of Risk/Benefit Analysis for the Use and Approval of Thrombolytic, Antiarrhythmic, and Hypolipidemic Agents

More books from Springer US

bigCover of the book Clinical Psycholinguistics by

bigCover of the book The New Dimensions of Warfarin Prophylaxis by

bigCover of the book Fiscal Federalism in Unitary States by

bigCover of the book Mechanisms and Pathogenesis by

bigCover of the book New and Renewable Technologies for Sustainable Development by

bigCover of the book Functional and Stereotactic Neurosurgery by

bigCover of the book The Postmortem Brain in Psychiatric Research by

bigCover of the book Ethics in Real Estate by

bigCover of the book Multisensory Control of Posture by

bigCover of the book Visual Event Detection by

bigCover of the book Legal Issues in Mental Health Care by

bigCover of the book Opioid Dependence by

bigCover of the book Advances in Clinical Child Psychology by

bigCover of the book Population Genetics by

We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy